Washington Trust Advisors, Inc. Horizon Therapeutics Public LTD CO Transaction History

Washington Trust Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$107.32 - $113.5 $1,931 - $2,043	-18 Reduced 69.23%	8 $0
Q4 2022 Feb 08, 2023	SELL	$62.39 - $113.8 $16,408 - $29,929	-263 Reduced 91.0%	26 $2,000
Q3 2022 Oct 14, 2022	BUY	$58.92 - $84.67 $530 - $762	9 Added 3.21%	289 $18,000
Q2 2022 Jul 25, 2022	SELL	$79.4 - $116.36 $24,217 - $35,489	-305 Reduced 52.14%	280 $22,000
Q1 2022 May 05, 2022	BUY	$86.42 - $109.81 $950 - $1,207	11 Added 1.92%	585 $61,000
Q4 2021 Feb 11, 2022	BUY	$98.56 - $119.91 $56,573 - $68,828	574 New	574 $62,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Washington Trust Advisors, Inc. with notifications on news.